In 1978, a deadly parvovirus outbreak emerged among dogs, prompting a significant response from scientists. A team at Cornell, led by Leland "Skip" Carmichael, created a vaccine that has saved countless lives. Recently, a study authored by Colin Parrish and others unveiled how host antibodies interact with parvovirus, providing vital insights that may improve vaccines and treatments. This research, supported by NIH and the Cornell Canine Health Center, builds on earlier work indicating that puppy responses to the virus produce limited but specific antibody types.
The study published in PNAS sheds light on how host antibodies neutralize parvovirus, improving our understanding and advancing vaccine and treatment development.
Colin Parrish described the development of the parvovirus vaccine as 'a worldwide relief, a miracle,' highlighting its significance during the epidemic.
Collection
[
|
...
]